Energy Focus, Inc. — Form 10-Q Summary
Reporting period: Quarter and six months ended June 30, 2020. Energy Focus designs, develops, manufactures, markets, and sells energy-efficient LED lighting and controls for commercial and military maritime markets.
Financial results
| Metric | Q2 2020 | Q2 2019 | H1 2020 | H1 2019 |
|---|---|---|---|---|
| Net sales | $3.335 million | $3.082 million | $7.118 million | $6.259 million |
| Gross profit (loss) | $1.343 million | $(0.109) million | $2.375 million | $(0.011) million |
| Gross margin | 40.3% | (3.5)% | 33.4% | (0.2)% |
| Operating loss | $(0.929) million | $(2.149) million | $(2.192) million | $(4.952) million |
| Net loss | $(4.340) million | $(2.254) million | $(4.881) million | $(5.119) million |
| Basic and diluted loss per share | $(1.36) | $(0.91) | $(1.55) | $(2.09) |
Q2 revenue increased about 8% year over year; H1 revenue increased 13.7%. Military maritime (MMM) sales drove the H1 increase: MMM sales rose 102% to $4.324 million, while commercial sales fell 32% to $2.794 million. In Q2, commercial sales declined to $1.058 million from $2.131 million, while MMM sales rose to $2.277 million from $0.951 million.
Gross margin improved substantially, reflecting higher-margin product mix and favorable material and labor variances, as well as favorable inventory and warranty reserve effects. These reserve effects benefited Q2 gross margin by approximately $0.3 million; the comparable 2019 quarter included approximately $0.5 million of unfavorable inventory reserves. Operating expenses were $2.272 million in Q2 and $4.567 million in H1. H1 net loss improved modestly, but Q2 net loss increased largely because of a $3.3 million Q2 loss from revaluing warrant liabilities; the H1 warrant fair-value loss was $2.427 million. These fair-value charges are noncash accounting items.
Cash, debt, and liquidity
- At June 30, cash was $2.727 million, excluding $0.342 million of restricted cash. Cash and restricted cash totaled $3.069 million.
- H1 operating cash use was $0.703 million, versus $5.120 million in H1 2019. Investing cash use was $0.118 million; financing provided $3.198 million. Financing included the January equity-and-warrant offering, PPP borrowing, and credit-line borrowing.
- Reported debt totaled approximately $2.7 million: $1.331 million under the Austin credit line, $0.603 million on the Iliad note, and $0.795 million under the PPP loan. The company also reported a $4.011 million warrant liability, which is not included in that debt total.
- Current assets were $11.822 million and current liabilities $11.036 million. Stockholders’ equity was $1.714 million, down from $3.996 million at year-end 2019; accumulated deficit was $129.755 million.
- Management disclosed substantial doubt about the company’s ability to continue as a going concern. It said planned external funding, cost actions, inventory reduction, PPP proceeds, and sales and product initiatives, if successfully executed, were expected to support operations for the next 12 months and mitigate that doubt. Additional financing was not assured.
Changes, outlook, and key risks
- COVID-19 and demand: Commercial customers in healthcare, education, and commercial/industrial markets delayed orders and project starts. Management said the pandemic’s duration and effects on customers, suppliers, and logistics remained uncertain.
- Concentration: Two customers represented approximately 54% of H1 sales. U.S. Navy-related sales were approximately 53% of H1 revenue; the primary Navy distributor alone represented 39%. At quarter-end, that distributor accounted for 47% of trade receivables.
- Products and strategy: The company launched its EnFocus lighting-control platform in Q2 and reported positive customer feedback. It planned to launch UV disinfection products by year-end 2020; provisional patents had been filed. No quantified revenue or earnings guidance was provided.
- Funding and obligations: The company had approximately $8.5 million of outstanding inventory purchase commitments, including $1.9 million expected to ship in Q3. It continued to seek external financing and warned that inability to obtain funding could force it to reduce growth plans, cut costs or headcount, or curtail operations.
- Subsequent financing: On August 11, 2020, the company replaced the Austin facility with inventory financing of up to the lower of $3.0 million or the eligible-inventory borrowing base, and receivables financing of up to the lower of $2.5 million or the eligible-receivables borrowing base. These are borrowing-base facilities, not guaranteed full availability. Austin termination incurred a $100,000 breakage fee. The inventory facility includes a 1% monthly service fee and an $18,490 minimum monthly combined charge; the receivables facility bears interest at prime plus 2%.
- Capital structure: A 1-for-5 reverse stock split became effective June 11, 2020 to address Nasdaq’s minimum bid-price requirement. The January equity offering generated approximately $2.3 million in net proceeds and included warrants. At June 30, 721,546 warrants remained outstanding; their liability classification and fair value can create significant noncash earnings volatility. The converted Series A preferred stock is convertible into common stock at a one-for-five ratio.
- The PPP loan bears 1% interest and may be forgiven for qualifying use, but forgiveness was not assured. No material legal proceedings were reported. Management concluded disclosure controls were effective as of June 30, 2020.
Important facts for investors to verify
- Whether the August 2020 borrowing-base facilities provide sufficient usable liquidity, and their actual costs, availability, and covenant compliance.
- Whether the company can reduce operating cash burn and obtain additional financing before liquidity is depleted.
- Whether commercial order delays persist, and whether MMM demand can offset them given the concentration in Navy-related customers.
- Whether the reported gross-margin improvement is repeatable without favorable reserve adjustments.
- The status of PPP loan forgiveness, the $8.5 million purchase commitments, and the potential cash or dilution effects of outstanding warrants and preferred shares.